Osmind

As a Public Benefit Corporation serving 800+ independent psychiatry practices, we've seen how technology and collaboration make mental health treatment more accessible, and we know the best ideas come from bringing the right people together.

#BHT2025

That's why Osmind is sponsoring the Behavioral Health Tech Conference 2025.

You never know which conversation will spark a wave of transformation in behavioral health care.

Vagal Nerve Stimulation (VNS) for Depression: The Treatment That Gets Better Over Time | Osmind Vagal nerve stimulation (VNS) for depression improves progressively over 12-24 months with remarkably low relapse rates. Learn patient selection criteria, Medicare RECOVER trial access, insurance appe...

Most psychiatric treatments lose effectiveness over time. Vagal nerve stimulation does the opposite.

Lucian Manu, M.D. has helped over 20 patients access VNS at Stony Brook University, many who'd exhausted every other option.

Get the full guide to VNS here:

www.osmind.org/blog/vagal-n...

Sign Up for the Psychiatry Collective Dive into the latest research, innovative treatments, technology, and policy developments shaping the future of psychiatry. Join us on this journey to discover what's next in mental health care so you...

Not a community member yet? Sign up here: osmind.org/join-communi...

Already a member, dive in here: community.osmind.org/feed

"Instead of mindlessly scrolling, I have something productive. It keeps me excited, keeps me engaged. I feel like I have something to offer when I answer a question."

Join The Psychiatry Collective and connect with clinicians solving the same problems you face every day:

This community tackles real practice challenges: outcome-based care workflows, AI integration, patient rating scales, documentation strategies, and burning case questions.

"Just having a community where you get to learn from others, see how other people might be using different tools, how they might fit it into their workflows... I think: how can I take this and adapt it within my own system? That's the most direct benefit."

Solo practice means you're good at what you do. It also means you're isolated.

Dr. Jacob Behrens, MD runs Envision ADHD in Wisconsin. He joined The Psychiatry Collective to stay current on emerging treatments—but discovered something more valuable than research updates.

Integrating Ketamine with Adjunct Therapies: TMS, Spravato, and More | Osmind Ketamine works fast but fades. TMS builds slowly but lasts. Spravato is covered by insurance. Learn when combinin treatments for depression delivers what one can't alone—and which patients benefit mos...

Impulse control came back online. That's one of many things that TMS does.

But TMS won't help that patient reprocess childhood trauma or shift their relationship to painful memories. That's what ketamine does. Different tools for different jobs.

www.osmind.org/blog/ketamine-tms-spravato-depression

Food fell out of the refrigerator. For most people, mildly annoying. For one patient with depression, it used to trigger hours of rage and dysregulation.

After TMS treatment, it happened again. But this time, he picked up the food, put it back, moved on. His wife stood there stunned.

"This TMS chair is not Santa's sleigh; it doesn't run on belief."

For patients already carrying the weight of their illness, removing the burden of belief can be transformative.

Listen to the full conversation by searching "Psychiatry Tomorrow" on your favorite podcast platform!

Check on your loved ones. Check in with yourself. We're here for each other.

Mental healthcare takes a village. We need each other.

We're grateful for the researchers asking hard questions, the clinicians showing up every day, and the pioneers trying new approaches when the old ones aren't enough. You're making a difference.

After 15 years building TMS programs, she sees resistance to brain stimulation like refusing to join psychiatry's tomorrow.

"It's no different than deciding I'm putting every patient on Prozac and staying in the eighties," she says. "You don't want to practice medicine in the olden days."

"The cat's out of the bag. I don't see a world in future psychiatry that's just medicine and therapy."

Martha B. Koo, M.D. doesn't mince words about where psychiatry is headed.

We're honored that Osmind has been selected from thousands of companies globally as a finalist for:

The Digital Health Hub Foundation - Digital Health Awards
in the Best in Class track - Mental and Behavioral Health category!

Optimize Your Psychiatry Practice’s Financial Health with this Revenue Cycle Management Guide | Osmind Many psychiatry practices leave significant revenue on the table due to billing inefficiencies. Here's how to close that gap. This practical guide covers key revenue cycle management terms, timelines,...

www.osmind.org/blog/psychia...

Learn:

•Which metrics actually matter (and what healthy ranges look like)

•Where revenue typically leaks in psychiatry billing

•When to handle billing in-house vs. partner with specialists

Make informed decisions about your practice finances:

Most psychiatry practices lose revenue to billing inefficiencies, but don't realize it until cash flow becomes a crisis. Here's your 101 guide to Revenue Cycle Management (no MBA required).

How TMS is Rewiring Psychiatry with Martha Koo, MD | Osmind Dr. Martha Koo bought her first TMS machine in 2009 when colleagues thought she was

Interventions like TMS can shift how your benchmark for treatment goals. Maybe "stable" isn't the same as "thriving."

Full "Psychiatry Tomorrow" episode available on our blog Spotify, or Apple Podcasts! www.osmind.org/blog/tms-rew...

"You lose perspective. I never met those people at their 100%..You see how people pop with TMS," Koo explains. "They come to life with so much more color!"

"I'm good, but I'm not my true full self."

Dr. Martha B. Koo, M.D., LFAPA, FASAM, FCTMSS heard this from her own therapy patients after placing a simple TMS brochure in her waiting room.

These were patients she considered stable on medication and therapy.

Must be a Psychedelic Medicine Association (PMA) member to attend. To learn more and sign up visit:

members.psychedelicmedicineassociation.org/c/webinars/i...

•Best practices for integrating these modalities into individualized treatment plans for patients with mood disorders

🗓️Tuesday, September 30th • 5 PM Pacific / 8 PM Eastern

•Appropriate patient populations and selection criteria for adjunctive therapy

•Current evidence regarding the efficacy and safety of combining or sequencing these treatments

•Mechanisms of action and clinical indications for ketamine, TMS, and esketamine (Spravato)

Join William Sauvé, MD (Osmind CMO) and David Feifel, MD, PhD (Kadima Neuropsychiatry Institute Founder) for a candid discussion hosted by Psychedelic Medicine Association about what they're seeing work—and what isn't.

Here's what you'll learn:

Ketamine + TMS + Spravato: What's working in real practice?

If you're offering ketamine as a treatment, you've probably wondered about combining it with TMS or Spravato. The data is promising, but practical questions are endless: patient selection, sequencing, what actually works.

Dr. Albright also capped the conference off helping bring interventional psychiatry to more clinicians. Her work continues to drive the field forward!

Cheers to more conversations on how we can use data, technology, and research to help people benefit from innovative mental health treatments!

➡️ Big shoutout to Osmind medical advisor, Brittany Albright MD, MPH, who gave many amazing talks, including a heartfelt tribute to Dr. Maletic, reminding clinicians, “We can be the medicine our patients need.”